1. Statistical considerations for clinical trials during the COVID-19 public health emergency Publication: [Silver Spring, MD] : Center for Drug Evaluation and Research, June 2020 Subject(s): Clinical Trials as TopicStatistics as TopicCOVID-19United StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. E9(R1) statistical principles for clinical trials: addendum : estimands and sensitivity analysis in clinical trials Publication: Silver Spring, MD : Center for Drug Evaluation and Research, May 2021 Subject(s): Clinical Trial Protocols as TopicClinical Trials as TopicStatistics as TopicUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration